WILBANKS SMITH & THOMAS ASSET MANAGEMENT LLC - CITIUS PHARMACEUTICALS INC ownership

CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 73 filers reported holding CITIUS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.

Quarter-by-quarter ownership
WILBANKS SMITH & THOMAS ASSET MANAGEMENT LLC ownership history of CITIUS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$76,000
-24.0%
49,0750.0%0.00%
-25.0%
Q3 2021$100,000
-39.0%
49,075
+3.8%
0.00%
-33.3%
Q2 2021$164,000
+355.6%
47,265
+136.3%
0.01%
+200.0%
Q1 2021$36,000
+80.0%
20,0000.0%0.00%
+100.0%
Q4 2020$20,000
-4.8%
20,0000.0%0.00%0.0%
Q3 2020$21,00020,0000.00%
Other shareholders
CITIUS PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Inspire Advisors, LLC 135,508$472,0000.15%
Wealth Advisory Solutions, LLC 156,850$546,0000.13%
Horst & Graben Wealth Management LLC 75,722$264,0000.07%
Miller Investment Management, LP 50,000$174,0000.03%
GSA CAPITAL PARTNERS LLP 44,655$155,0000.02%
Triton Wealth Management, PLLC 13,100$24,0000.01%
Renaissance Technologies 1,898,351$6,606,0000.01%
B. Riley Wealth Management, Inc. 19,000$66,0000.01%
Virtu Financial LLC 19,713$69,0000.01%
WILBANKS SMITH & THOMAS ASSET MANAGEMENT LLC 47,265$164,0000.01%
View complete list of CITIUS PHARMACEUTICALS INC shareholders